Treatments administered to patients positive or negative for anti-FH autoantibodies at disease onset
| Treatments | Anti-FH positive, n = 12 | Anti-FH negative, n = 30 | P-value (Fisher’exact test) |
|---|---|---|---|
| Dialysis | 6 (50%) | 15 (50%) | 1.00 |
| Plasmapheresis | 5 (42%) | 11 (37%) | 1.00 |
| Plasmapheresis followed by eculizumab | 3 (25%) | 3 (10%) | 0.33 |
| Eculizumab only | 2 (17%) | 1 (3%) | 0.19 |
| Supportive care only | 1 (8%) | 10 (33%) | 0.13 |
| Immunosupression | 8 (67%) | 9 (30%) | < 0.05 |
| Corticosteroids | 6 (50%) | 9 (30%) | 0.29 |
| Mycophenolate, cyclophosphamide | 4 (33%) | 0 (0%) | < 0.005 |
Values in this table represent number of patients and the percentage of the total